Trials / Unknown
UnknownNCT05297929
A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects
Bioequivalence of Irbesartan Tablets (0.15g/Tablet) in a Randomized, Open, Two-cycle, Two-crossover Single Fasting/Postprandial State in Healthy Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- The Affiliated Hospital of Qingdao University · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
To study the pharmacokinetics of test preparation and reference preparation irbesartan tablets (0.15g/tablet) in a single oral administration in fasting and fed state,respectively, in healthy adult subjects, and to evaluate the bioequivalence of the two preparations
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Irbesartan Tablet | Drug: Irbesartan Oral administration on an empty stomach／fed condition |
Timeline
- Start date
- 2022-02-17
- Primary completion
- 2022-04-09
- Completion
- 2022-12-31
- First posted
- 2022-03-28
- Last updated
- 2022-03-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05297929. Inclusion in this directory is not an endorsement.